FDA Rejects Replimune’s Melanoma Therapy Again Citing Unaddressed Study Concerns, Fueling Industry Debate
The U.S. Food and Drug Administration (FDA) has delivered a second significant blow to Replimune...
Knowledge and News for the Global Fight Against Cancer.
The U.S. Food and Drug Administration (FDA) has delivered a second significant blow to Replimune...
Lumanity’s Cancer Progress 2026, held on April 9th at the New York Genome Center, served...
The eight women highlighted by CRI represent a powerful continuum of courage, intellectual curiosity, and...
Each year, a dedicated community converges with a profound, shared purpose: to commemorate a life...
Despite significant strides in prevention through robust screening programs and widespread human papillomavirus (HPV) vaccination,...
February marks National Cancer Prevention Month, a crucial period dedicated to spotlighting the profound impact...
Adrienne Skinner’s journey is a powerful testament to the rapidly evolving landscape of cancer treatment,...
Colorectal cancer, encompassing both colon and rectal cancers, has emerged as a formidable health challenge,...
A New Era of Survival: The Numbers Behind the Breakthroughs In a significant milestone for...
Colorectal cancer (CRC), once predominantly considered a disease of older age, is now surging at...